Proletariat Therapeutics Inc
- Biotech or pharma, therapeutic R&D
PTX-078 is designed to prevent the toxic consequences of cisplatin-based chemo. Phase 1b done, Phase 2 is next.
PTX-501 is designed to prevent systemic microvascular ischemia (low blood flow), dialysis induced heart disease, neurocognitive impairment, and muscle cramps in patients undergoing dialysis and is eligible for reimbursement vis-à-vis an ESRD addon payment. Phase 1b done. Phase 2 is next.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}